Fabiana da Silva Alves, MS: The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication

Name: Fabiana da Silva Alves, MS: The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication
SKU: 4168
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 41 No. 1 Articles Tags: brain-imaging, dick-veltman, dopaminergic-manipulation, fabiana-da-silva-alves, fmri, martijn-figee, md, ms, negative-symptoms, phd, phmri, prefrontal-hypoactivity, schizophrenia-patients, schizophrenia-treatment, subcortical-hyperactivity, therese-van-amelsvoort, work-memory

Description

Description

Fabiana da Silva Alves, MS

BRAIN IMAGING

The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication

Fabiana da Silva Alves, MS, Martijn Figee, MD, Therese van Amelsvoort, MD, PhD, Dick Veltman, MD, PhD, and Lieuwe de Haan, MD, PhD

PB-41-1-09-Alves

Fabiana da Silva Alves, MS: The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication

Description

Fabiana da Silva Alves, MS

BRAIN IMAGING

The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication

Fabiana da Silva Alves, MS, Martijn Figee, MD, Therese van Amelsvoort, MD, PhD, Dick Veltman, MD, PhD, and Lieuwe de Haan, MD, PhD

Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

P. Murali Doraiswamy, MD: Donepezil for Cognitive Decline Following Coronary Artery Bypass Surgery: A Pilot Randomized Controlled Trial

Trisha Suppes, MD, PhD: Awareness of Metabolic Concerns and Perceived Impact of Pharmacotherapy in Patients with Bipolar Disorder: A Survey of 500 US Psychiatrists

Srinivas G. Rao, MD, PhD: Understanding The Fibromyalgia Syndrome

Fabiana da Silva Alves, MS: The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication

Description

Fabiana da Silva Alves, MS

BRAIN IMAGING

The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication

Fabiana da Silva Alves, MS, Martijn Figee, MD, Therese van Amelsvoort, MD, PhD, Dick Veltman, MD, PhD, and Lieuwe de Haan, MD, PhD

Related products

Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

P. Murali Doraiswamy, MD: Donepezil for Cognitive Decline Following Coronary Artery Bypass Surgery: A Pilot Randomized Controlled Trial

Trisha Suppes, MD, PhD: Awareness of Metabolic Concerns and Perceived Impact of Pharmacotherapy in Patients with Bipolar Disorder: A Survey of 500 US Psychiatrists

Srinivas G. Rao, MD, PhD: Understanding The Fibromyalgia Syndrome